Healthcare Pharmaceutical Biotech

10 Years, 10 Stories: From Curiosity to Career

October 30, 2026 2:45 PM

Over the past decade, employees at MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, have turned a global employee volunteer program into a real movement. As SPARK™ marks its 10th anniversary, the "10 Years, 10 Stories" series reflects on a decade of impact and the employees, students, and organizations that have been at the heart of the program. In the final article in this series, former students who...

Read more

ADM Tronics Closes First Two Tranches of Private Placement and Strengthens Board of Directors

October 30, 2026 2:45 PM

ADM Tronics Unlimited, Inc. (OTCQB:ADMT) ("ADM Tronics" or the "Company") today announces that on October 27, 2026, it completed an initial $1.3 million closing of a private placement of shares of common stock at a price of $0.10 per share, together with warrants to purchase a number of shares of common stock equal to 50% of the shares purchased. On October 28, 2026, the Company completed a second closing of $250,000 on the same terms, bringing...

Read more

Wasatch Back Beauty Lab Expands Skin Rejuvenation Services with Tixel Technology

October 30, 2026 11:55 AM

Wasatch Back Beauty Lab, a medical aesthetics and wellness practice serving Heber City and the surrounding Wasatch Back community, today announced the addition of Tixel-C to its skin rejuvenation services. The compact fractional skin-resurfacing system expands the practice's options for patients seeking improvement in visible signs of aging, uneven texture and tone, skin laxity, and textural concerns related to scarring. Led by owner and nurse...

Read more

Bluejay Diagnostics Announces 1-for-4 Reverse Stock Split

October 30, 2026 10:30 AM

Bluejay Diagnostics, Inc. (NASDAQ:BJDX) ("Bluejay" or the "Company"), a medical diagnostics company focused on improving patient outcomes through its Symphony™ near-patient diagnostic platform, today announced that the Company's Board of Directors has approved a reverse stock split of its shares of common stock at a ratio of 1-for-4 (the "Reverse Stock Split"). The Reverse Stock Split will become effective at 12:01 a.m. Eastern Time on November...

Read more

Restoring Volume, Stimulating Collagen: BODYWELLE's Dr. Alonso Martin Discusses Sculptra and Radiesse

October 30, 2026 10:00 AM

BODYWELLE, the Miami Beach longevity and functional medicine practice led by Alonso Martin, MD, offersSculptra and Radiesse for patients concerned with facial volume loss and declining skin firmness. Both are injectable treatments that work in part by prompting the body to produce new collagen. Treatments are performed under physician supervision at the practice's Miami Beach office. Alonso Martin, MD, BODYWELLE founder specializing in Sculptra...

Read more

Surmodics Launches MetalPro(TM) Direct-to-Metal Hydrophilic Coatings for Medical Devices

October 30, 2026 9:37 AM

Surmodics Inc., a leading provider of surface technologies and performance coatings for the medical device industry, today announced at the opening of the Transcatheter Cardiovascular Therapeutics (TCT) conference in San Diego the launch of MetalPro™ direct-to-metal UV cure hydrophilic coatings engineered to bond directly to metal surfaces without primers or tie-layers. By eliminating additional tie-layers, MetalPro simplifies coating...

Read more

CVS Health: How Education and Everyday Action Can Support Medication Safety

October 30, 2026 8:45 AM

Originally published on CVS Health Company Newsroom Young people encounter complex messages about medications, substance use and mental health. Helping them make informed choices starts with trusted adults who are prepared to listen, answer questions and share clear, age-appropriate information. Red Ribbon Week, observed October 23-31, is a national campaign that brings families, schools and communities together to support healthy choices among...

Read more

Valion Bio Advancing Entolimod into U.S. Government-Funded Therapeutic Efficacy Study Following Positive Safety Results

October 30, 2026 7:50 AM

Valion Bio, Inc. (NASDAQ:VBIO) ("Valion" or the "Company"), a clinical-stage biopharmaceutical company developing biologics that activate innate immune pathways for cytoprotection and immune modulation, today announced that the Armed Forces Radiobiology Research Institute ("AFRRI") will be evaluating the therapeutic efficacy of Entolimod. This phase will evaluate whether treatment administered after radiation exposure improves survival in a...

Read more

Dr. Feliciano Serrano Connects Kidney Care With Clear Communication for Los Angeles Families

October 29, 2026 7:08 PM

A kidney appointment often begins with questions that a laboratory report cannot answer on its own. What does a change in kidney function mean? Is a medication still appropriate? Which symptoms should be reported? What happens if dialysis becomes necessary? For Spanish-speaking patients and their families, being able to discuss those questions clearly can be an important part of participating in care. Dr. Feliciano Serrano. Portrait supplied...

Read more

Dermata Advances Second Tome Skincare Product Toward Expected 2027 Launch with Initiation of Acne Clinical Trial

October 29, 2026 4:05 PM

Dermata Therapeutics, Inc. (Nasdaq:DRMA) ("Dermata" or the "Company"), a science-driven leader in dermatologic solutions, today announced enrollment of the first participant in a clinical trial evaluating Tome Clearing Treatment, the Company's once-weekly acne treatment, in participants with acne. The Company expects to launch this second commercial product in H1 2027. The initiation of this clinical trial marks another milestone in Dermata's...

Read more

Pro-Dex, Inc. Announces Fiscal 2027 First Quarter Results

October 29, 2026 4:00 PM

PRO-DEX, INC. (NASDAQ:PDEX) today announced financial results for its fiscal 2027 first quarter ended September 30, 2026. The Company also filed its Quarterly Report on Form 10-Q for the first quarter of fiscal year 2027 with the Securities and Exchange Commission today. Quarter Ended September 30, 2026 Net sales for the three months ended September 30, 2026, increased $2.1 million, or 11%, to $20.6 million from $18.5 million for the three...

Read more

Zenuva CBD Gummies Reviews 2026: What Does Your Order Include? Pricing, Renewals and Return Terms

October 29, 2026 3:30 PM

Quick disclosure, then straight into it: a commission is earned if you purchase through links below, and product claims are attributed to the brand, not independently endorsed by this publication. Zenuva CBD Gummies is not an FDA-approved medication and isn't intended for anyone under 21. Consult a healthcare provider before use, especially if pregnant, breastfeeding, managing a medical condition, or taking medications. Official site:...

Read more

Experts and Federal Officials Agree: Natural Kratom Leaf Should Not Be Banned

October 29, 2026 2:27 PM

Federal regulators have already separated natural kratom leaf from concentrated synthetic 7-OH and other novel concentrated synthetic alkaloid products including MGM-15, MGM-16, and Mitragynine Pseudoindoxyl (MGPI). WATCH: What federal officials and leading researchers say: expertsonnaturalkratomleaf.co In July 2025, the FDA recommended scheduling concentrated synthetic 7-OH without restricting natural kratom leaf. DEA's temporary scheduling of...

Read more

Utah Medical Products, Inc. Reports Corrected Results of Tender Offer

October 29, 2026 12:10 PM

On September 24, Utah Medical Products, Inc. (Nasdaq:UTMD) offered to purchase up to 650,000 shares of its common stock at $75.00 per share. The issuer Tender Offer expired Tuesday October 27. In short, 327,740 shares were purchased for $24,580,500. Remaining UTMD shares outstanding at this date are 2,849,041 including 1,775 employee option shares exercised in October. In addition, $107,720 administration fees will be paid to the depositary and...

Read more

MiVu Mucosal Integrity Testing System Marks 25,000 Procedures Performed

October 29, 2026 12:00 PM

Diversatek Healthcare announced that the MiVu™ Mucosal Integrity Testing System has surpassed 25,000 procedures performed, marking a significant milestone for its clinical adoption nationwide. MiVu™ delivers objective, point-of-care data during endoscopy that differentiates GERD, EoE, and Non-GERD, supporting diagnostic confidence and real-time treatment decisions for gastrointestinal providers. What is Mucosal Integrity Testing? The MiVu™...

Read more

From Global Manufacturing to Overseas Shelves HOMENVOY Builds an International Nutrition and Wellness Value Chain With Global Industry Partners

October 29, 2026 11:05 AM

For a nutrition product to cross borders and reach a retail shelf, it has to pass through demand confirmation, production scheduling, quality testing, and logistics. For HOMENVOY, selling globally is first a coordination problem and only then a channel problem. The whole-family nutrition brand HOMENVOY was established by HOMENVOY (GLOBAL) GROUP LIMITED, a company founded in Hong Kong, China, which has made mobilising international resources a...

Read more

Hair Transplants Are Now Covered by Insurance

October 29, 2026 11:00 AM

Private health insurance is opening new possibilities for transgender and nonbinary patients seeking gender-affirming hair restoration. With thousands of surgeries performed, Seattle-based plastic surgeon Dr. Javad Sajan of Allure Esthetic accepts all private insurance for transgender hair transplant procedures, which include follicular unit transplant (FUT), also known as the strip method, and follicular unit extraction (FUE). Dr. Sajan is one...

Read more

CORRECTION: SOD Sciences Welcomes Vivos Therapeutics as Strategic Investor and Partner in the ReBalU Primed Cell Test

October 29, 2026 10:52 AM

SOD Sciences, Inc. ("SOD Sciences" or "SOD") today announced the closing of its strategic partnership with Vivo Therapeutics, Inc. (Nasdaq:VVOS) ("Vivos"). Vivos has acquired an 11% equity interest in SOD Sciences, a 50% ownership interest in SOD's pseudohypoxia patent, and a 50% ownership interest in SOD's pseudohypoxia early‑warning test, the ReBalU Primed Cell Test, in exchange for $12,000,000 of Vivos Series D Convertible Preferred Stock,...

Read more

Boehringer Ingelheim Celebrates a Decade of Angels Initiative and Helping 28+ Million Patients Get Better Stroke Care

October 29, 2026 10:30 AM

Boehringer Ingelheim, today, on World Stroke Day, celebrates 10 years of the Angels Initiative and bringing better stroke care to more than 28 million patients worldwide, through education and connecting hospitals, emergency medical services and communities to improve awareness and healthcare. Launched in 2016, Boehringer Ingelheim's Angels Initiative helps hospitals worldwide to become "stroke-ready", so that patients who have just suffered a...

Read more

Glidewell and ORB Innovations Announce Publication of Smart Nightguard Validation Abstract in Journal of Sleep Research

October 29, 2026 10:00 AM

Glidewell, America's leading dental laboratory and continuous innovation partner, in conjunction with ORB Innovations, has announced the publication of the abstract "Validation of a Smart Nightguard for Sleep Behaviour and Head Position Monitoring" in the Journal of Sleep Research, Volume 35, Issue S1 (Abstracts of the 28th Congress of the European Sleep Research Society, 20 - 23 October 2026, Maastricht, The Netherlands). The abstract,...

Read more